Related references
Note: Only part of the references are listed.Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir
A. Ong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
Goh Eun Chung et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-na⟨ve patients with chronic hepatitis B
Su Rin Shin et al.
HEPATOLOGY INTERNATIONAL (2011)
Treatment of chronic hepatitis B: Evolution over two decades
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern
J. Inoue et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
Jung Min Lee et al.
ANTIVIRAL THERAPY (2010)
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
Thomas Berg et al.
GASTROENTEROLOGY (2010)
Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy
Hong Joo Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Efficacy of Adefovir Add-On Lamivudine Rescue Therapy Compared With Switching to Entecavir Monotherapy in Patients With Lamivudine-Resistant Chronic Hepatitis B
Han Jak Ryu et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon
Patrick Marcellin et al.
LIVER INTERNATIONAL (2010)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study
Adriano M. Pellicelli et al.
CLINICAL THERAPEUTICS (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up
Hiromi Yatsuji et al.
JOURNAL OF HEPATOLOGY (2008)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
Irene Rapti et al.
HEPATOLOGY (2007)
Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
J. E. Yeon et al.
GUT (2006)
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
Florian van Boemmel et al.
HEPATOLOGY (2006)
Hepatitis B virus-related cirrhosis: Natural history and treatment
CM Chu et al.
SEMINARS IN LIVER DISEASE (2006)
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
Yoon-Seon Lee et al.
HEPATOLOGY (2006)
Hepatitis B virus genotypes in korea: An endemic area of hepatitis B virus infection
BC Song et al.
INTERVIROLOGY (2005)
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
R Perrillo et al.
GASTROENTEROLOGY (2004)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Histological outcome during long-term lamivudine therapy
JL Dienstag et al.
GASTROENTEROLOGY (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
SW Schalm et al.
GUT (2000)
Share Paper
